Aehr Test Systems Slides as Profit-Taking Hits Recent AI-Driven Rally

Aehr Test Systems (AEHR) is down 14.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The catalyst appears unclear, but the selloff looks most consistent with profit-taking after a sharp recent run-up rather than a new company-specific negative announcement. This could be because investors are pulling back from volatile semiconductor and AI-linked names even after Aehr posted strong orders, backlog growth, and an upbeat fiscal 2027 outlook.

Details:

Aehr’s investor relations page showed the stock near $123.78 on August 18, 2026, down about 15% on the day, with no fresh negative press release or SEC filing listed alongside the move.

On August 12, the company announced a $22 million follow-on order from its lead wafer-level AI processor customer, with shipments expected over the next six months to a manufacturing partner in Taiwan.

In July, Aehr reported record quarterly bookings of $60.7 million, effective backlog of about $100.6 million, and projected fiscal 2027 revenue of $130 million to $150 million.

Even with those positives, the company’s fiscal 2026 revenue was lower than the prior year and AI-related chip stocks have been swinging sharply, which may have made AEHR vulnerable to a fast reversal after its recent surge.

Sources:

Aehr Test Systems, SEC, Associated Press

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$AEHR Insider Trading Activity

$AEHR insiders have traded $AEHR stock on the open market 58 times in the past 6 months. Of those trades, 0 have been purchases and 58 have been sales.

Here’s a breakdown of recent trading of $AEHR stock by insiders over the last 6 months:

GAYN ERICKSON (President and CEO) has made 0 purchases and 4 sales selling 192,824 shares for an estimated $16,020,509.
GEOFFREY GATES SCOTT (Director) has made 0 purchases and 7 sales selling 135,000 shares for an estimated $12,306,020.
RHEA J POSEDEL (Director) has made 0 purchases and 9 sales selling 100,892 shares for an estimated $9,129,021.
HOWARD T SLAYEN (Director) has made 0 purchases and 4 sales selling 57,519 shares for an estimated $5,763,340.
ALBERTO SALAMONE (EVP, PPBI BUSINESS) has made 0 purchases and 4 sales selling 39,672 shares for an estimated $3,997,237.
ADIL ENGINEER (Chief Operating Officer) has made 0 purchases and 6 sales selling 31,813 shares for an estimated $3,104,724.
VERNON ROGERS (Exec VP of Sales & Mktg.) has made 0 purchases and 5 sales selling 29,805 shares for an estimated $2,475,620.
DONALD P. II RICHMOND (CTO) has made 0 purchases and 2 sales selling 32,762 shares for an estimated $2,326,659.
FARIBA DANESH (Director) has made 0 purchases and 3 sales selling 18,500 shares for an estimated $1,406,628.
LAURA OLIPHANT (Director) has made 0 purchases and 4 sales selling 11,098 shares for an estimated $972,623.
ALISTAIR N SPORCK (VP Contactor Business Unit) has made 0 purchases and 6 sales selling 9,000 shares for an estimated $795,886.
DIDIER WIMMERS (Executive VP of R&D) has made 0 purchases and 2 sales selling 5,400 shares for an estimated $385,731.
CHRIS SIU (CFO) has made 0 purchases and 2 sales selling 2,070 shares for an estimated $221,608.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$AEHR Hedge Fund Activity

We have seen 175 institutional investors add shares of $AEHR stock to their portfolio, and 108 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

AWM INVESTMENT COMPANY, INC. removed 1,219,163 shares (-76.5%) from their portfolio in Q2 2026, for an estimated $117,112,797
FMR LLC removed 1,135,809 shares (-53.0%) from their portfolio in Q2 2026, for an estimated $109,105,812
BAILLIE GIFFORD & CO removed 1,086,856 shares (-84.2%) from their portfolio in Q2 2026, for an estimated $104,403,387
TWO SIGMA INVESTMENTS, LP added 950,242 shares (+443.3%) to their portfolio in Q2 2026, for an estimated $91,280,246
D. E. SHAW & CO., INC. added 887,130 shares (+305.6%) to their portfolio in Q2 2026, for an estimated $85,217,707
PRICE T ROWE ASSOCIATES INC /MD/ removed 842,316 shares (-62.4%) from their portfolio in Q2 2026, for an estimated $80,912,874
JPMORGAN CHASE & CO added 732,547 shares (+inf%) to their portfolio in Q2 2026, for an estimated $70,368,464

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$AEHR Analyst Ratings

Wall Street analysts have issued reports on $AEHR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

William Blair issued a "Outperform" rating on 03/02/2026

To track analyst ratings and price targets for $AEHR, check out Quiver Quantitative's $AEHR forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.